These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9047233)

  • 1. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity.
    Tedder TF; Inaoki M; Sato S
    Immunity; 1997 Feb; 6(2):107-18. PubMed ID: 9047233
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses.
    Tedder TF; Haas KM; Poe JC
    Biochem Soc Trans; 2002 Aug; 30(4):807-11. PubMed ID: 12196203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity.
    Sato S
    J Dermatol Sci; 1999 Dec; 22(1):1-10. PubMed ID: 10651223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19 can regulate B lymphocyte signal transduction independent of complement activation.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF
    J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity.
    Haas KM; Tedder TF
    Adv Exp Med Biol; 2005; 560():125-39. PubMed ID: 15934172
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
    Fearon DT; Carroll MC
    Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.
    Haas KM; Poe JC; Tedder TF
    J Immunol; 2009 Sep; 183(6):3661-71. PubMed ID: 19710450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalities.
    Wentink MW; Lambeck AJ; van Zelm MC; Simons E; van Dongen JJ; IJspeert H; Schölvinck EH; van der Burg M
    Clin Immunol; 2015 Dec; 161(2):120-7. PubMed ID: 26325596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
    Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD19/CD21 signal transduction complex of B lymphocytes.
    Tedder TF; Zhou LJ; Engel P
    Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement's participation in acquired immunity.
    Nielsen CH; Leslie RG
    J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 14. [B cell activated co-receptor].
    Ruan X; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):436-9. PubMed ID: 12905672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
    Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
    Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling by the CD19/CD21 complex on B cells.
    Carter RH; Barrington RA
    Curr Dir Autoimmun; 2004; 7():4-32. PubMed ID: 14719373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to lymphocyte surface antigens for cetacean homologues to CD2, CD19 and CD21.
    De Guise S; Erickson K; Blanchard M; DiMolfetto L; Lepper HD; Wang J; Stott JL; Ferrick DA
    Vet Immunol Immunopathol; 2002 Jan; 84(3-4):209-21. PubMed ID: 11777535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity.
    Sato S; Ono N; Steeber DA; Pisetsky DS; Tedder TF
    J Immunol; 1996 Nov; 157(10):4371-8. PubMed ID: 8906812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.